YINGLING JONATHAN MICHAEL 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jul 11, 2019
Insider Transaction Report
Form 4
YINGLING JONATHAN MICHAEL
SVP of Early Development
Transactions
- Award
Stock Option (Right to Buy)
2019-07-09+45,500→ 45,500 totalExercise: $2.52Exp: 2029-07-09→ Common Stock (45,500 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 9, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 9, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.